Comments

SAB Biotherapeutics Stock News

SABSNASDAQ
Logo brought to you by Benzinga Data
Trade with Public
Trade with Public
$4.00
0.194.99%
At close: Dec 15, 4:00 PM EST
$3.90
-0.10-2.50%
After Hours: 4:44 PM EST
Overview

News

EarningsOptionsAnalyst RatingsInsider TradesShort InterestStock Report

Latest SAB Biotherapeutics Stock News | NASDAQ:SABS | Benzinga

Get the latest news on SAB Biotherapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on SAB Biotherapeutics performance

People Also Watch

Molecular Partners AG
NASDAQ:MOLN
$4.02
-1.59%
Kalaris Therapeutics Inc
NASDAQ:KLRS
$8.67
2.00%
Innate Pharma SA
NASDAQ:IPHA
$1.84
-2.13%
Armata Pharmaceuticals Inc
AMEX:ARMP
$6.16
4.41%
Vistagen Therapeutics Inc
NASDAQ:VTGN
$4.42
0.68%
Genelux Corp
NASDAQ:GNLX
$4.16
1.96%
Enlivex Therapeutics Ltd
NASDAQ:ENLV
$0.88
2.04%
Tonix Pharmaceuticals Holding Corp
NASDAQ:TNXP
$18.74
-0.64%
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2025 Benzinga | All Rights Reserved